We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIDU icon
101
Baidu
BIDU
$35.6B
$31M 0.26%
149,472
– –
T icon
102
AT&T
T
$170B
$30.9M 0.26%
1,482,431
-5
-0% -$111
APLS
103
DELISTED
Apellis Pharmaceuticals
APLS
$30.5M 0.25%
555,374
– –
BMRN icon
104
BioMarin Pharmaceuticals
BMRN
$11.9B
$30.2M 0.25%
358,030
– –
HALO icon
105
Halozyme
HALO
$9.93B
$30.1M 0.25%
733,742
-12
-0% -$548
ECL icon
106
Ecolab
ECL
$79.7B
$29.9M 0.25%
143,869
-1
-0% -$213
DRNA
107
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$29.8M 0.25%
1,408,993
– –
KURA icon
108
Kura Oncology
KURA
$826M
$29.2M 0.24%
929,277
-5
-0% -$158
VMW
109
DELISTED
VMware, Inc
VMW
$29M 0.24%
215,460
-1
-0% -$143
MRSN
110
DELISTED
Mersana Therapeutics
MRSN
$28.7M 0.24%
44,887
+1
+0% +$485
INTU icon
111
Intuit
INTU
$86.3B
$28.6M 0.24%
78,478
– –
BILI icon
112
Bilibili
BILI
$7.55B
$28.2M 0.23%
341,998
– –
BAC icon
113
Bank of America
BAC
$438B
$27.7M 0.23%
950,374
+38
+0% +$1.31K
TXN icon
114
Texas Instruments
TXN
$254B
$27.4M 0.23%
174,022
+9
+0% +$1.56K
ENPH icon
115
Enphase Energy
ENPH
$4.82B
$27.4M 0.23%
162,282
-4
-0% -$718
SLAB icon
116
Silicon Laboratories
SLAB
$7.17B
$27.2M 0.23%
222,686
– –
EBAY icon
117
eBay
EBAY
$52.2B
$27.2M 0.23%
563,059
– –
SEDG icon
118
SolarEdge
SEDG
$2.37B
$27M 0.23%
88,194
-1
-0% -$302
SRPT icon
119
Sarepta Therapeutics
SRPT
$1.61B
$26.9M 0.22%
164,008
– –
WMS icon
120
Advanced Drainage Systems
WMS
$11.1B
$26.8M 0.22%
333,385
-10
-0% -$977
IOVA icon
121
Iovance Biotherapeutics
IOVA
$2.09B
$26.4M 0.22%
592,050
-12
-0% -$497
HRTX icon
122
Heron Therapeutics
HRTX
$93.1M
$26.2M 0.22%
1,289,773
– –
QRVO icon
123
Qorvo
QRVO
$7.98B
$26M 0.22%
163,099
– –
LBRDK icon
124
Liberty Broadband Class C
LBRDK
$4.7B
$25.5M 0.21%
167,543
– –
CDNS icon
125
Cadence Design Systems
CDNS
$95.2B
$25M 0.21%
190,455
-15
-0% -$2.01K
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.